Home/Filings/4/0001127602-21-019437
4//SEC Filing

Finke Daniel P 4

Accession 0001127602-21-019437

CIK 0000064803other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:48 PM ET

Size

13.7 KB

Accession

0001127602-21-019437

Insider Transaction Report

Form 4
Period: 2021-06-07
Finke Daniel P
EVP/Pres, Health Care Benefits
Transactions
  • Exercise/Conversion

    Common Stock

    2021-06-07$54.19/sh+32,320$1,751,42160,903.584 total
  • Sale

    Common Stock

    2021-06-07$86.60/sh37,594$3,255,64023,309.584 total
  • Exercise/Conversion

    Stock Option

    2021-06-0732,32032,322 total
    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (32,320 underlying)
Holdings
  • Common Stock (restricted)

    25,701
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (82,066 underlying)
    82,066
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (54,332 underlying)
    54,332
  • Common Stock (pep)

    3,041.584
  • Stock Option

    Exercise: $52.37From: 2022-05-31Exp: 2029-05-31Common Stock (28,640 underlying)
    28,640
Footnotes (6)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share.
  • [F3]Option became exercisable in four equal annual installments, beginning on 4/1/2020.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F5]Option becomes exercisable in four equal installments, commencing 4/1/2022.
  • [F6]Option becomes exercisable in three equal installments, commencing 5/31/2022.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001844305

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:48 PM ET
Size
13.7 KB